These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 35770849)
1. Bioinspired Vascular Stents with Microfluidic Electrospun Multilayer Coatings for Preventing In-Stent Restenosis. Cheng Y; Zhang X; Liu R; Li Y; Zeng J; Zhou M; Zhao Y Adv Healthc Mater; 2022 Sep; 11(17):e2200965. PubMed ID: 35770849 [TBL] [Abstract][Full Text] [Related]
2. An electrospun fiber-covered stent with programmable dual drug release for endothelialization acceleration and lumen stenosis prevention. Zhang Y; Wang J; Xiao J; Fang T; Hu N; Li M; Deng L; Cheng Y; Zhu Y; Cui W Acta Biomater; 2019 Aug; 94():295-305. PubMed ID: 31195144 [TBL] [Abstract][Full Text] [Related]
3. Surface modification of endovascular stents with rosuvastatin and heparin-loaded biodegradable nanofibers by electrospinning. Janjic M; Pappa F; Karagkiozaki V; Gitas C; Ktenidis K; Logothetidis S Int J Nanomedicine; 2017; 12():6343-6355. PubMed ID: 28919738 [TBL] [Abstract][Full Text] [Related]
4. Design, preparation and performance of a novel drug-eluting stent with multiple layer coatings. Hu T; Lin S; Du R; Fu M; Rao Q; Yin T; Huang Y; Wang G Biomater Sci; 2017 Aug; 5(9):1845-1857. PubMed ID: 28676873 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of electrospun PLLA/PEGDMA polymer coatings for vascular stent material. Boodagh P; Guo DJ; Nagiah N; Tan W J Biomater Sci Polym Ed; 2016 Aug; 27(11):1086-99. PubMed ID: 27137629 [TBL] [Abstract][Full Text] [Related]
6. Heparin and Vascular Endothelial Growth Factor Loaded Poly(L-lactide-co-caprolactone) Nanofiber Covered Stent-Graft for Aneurysm Treatment. Wang J; An Q; Li D; Wu T; Chen W; Sun B; El-Hamshary H; Al-Deyab SS; Zhu W; Mo X J Biomed Nanotechnol; 2015 Nov; 11(11):1947-60. PubMed ID: 26554154 [TBL] [Abstract][Full Text] [Related]
7. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer. Lin Q; Ding X; Qiu F; Song X; Fu G; Ji J Biomaterials; 2010 May; 31(14):4017-25. PubMed ID: 20149438 [TBL] [Abstract][Full Text] [Related]
8. Euonymine inhibits in-stent restenosis through enhancing contractile phenotype of vascular smooth muscle cells via modulating the PTEN/AKT/mTOR signaling pathway. Zhang L; Tao Y; Yang R; Hu Q; Jia J; Yu M; He B; Shen Z; Qin H; Yu Z; Chen P Phytomedicine; 2022 Dec; 107():154450. PubMed ID: 36174454 [TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro analyses of the effects of a novel high-nitrogen low-nickel coronary stent on reducing in-stent restenosis. Wang J; Song C; Xiao Y; Liu B J Biomater Appl; 2018 Jul; 33(1):64-71. PubMed ID: 29720017 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Curcio A; Torella D; Indolfi C Circ J; 2011; 75(6):1287-96. PubMed ID: 21532177 [TBL] [Abstract][Full Text] [Related]
11. The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents. Tang C; Wang G; Wu X; Li Z; Shen Y; Lee JC; Yu Q J Vasc Surg; 2011 Feb; 53(2):461-71. PubMed ID: 21129910 [TBL] [Abstract][Full Text] [Related]
12. Multi-functional plant flavonoids regulate pathological microenvironments for vascular stent surface engineering. Liu L; Lan X; Chen X; Dai S; Wang Z; Zhao A; Lu L; Huang N; Chen J; Yang P; Liao Y Acta Biomater; 2023 Feb; 157():655-669. PubMed ID: 36436757 [TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin- and Heparin-Loaded Poly(l-lactide- co-caprolactone) Nanofiber Aneurysm Stent Promotes Endothelialization via Vascular Endothelial Growth Factor Type A Modulation. Liu P; Liu Y; Li P; Zhou Y; Song Y; Shi Y; Feng W; Mo X; Gao H; An Q; Zhu W ACS Appl Mater Interfaces; 2018 Dec; 10(48):41012-41018. PubMed ID: 30403126 [TBL] [Abstract][Full Text] [Related]
14. Study of novel coating strategy for coronary stents: simutaneous coating of VEGF and anti- CD34 antibody. Song CL; Li Q; Yu YP; Wang G; Wang JP; Lu Y; Zhang JC; Diao HY; Liu JG; Liu YH; Liu J; Li Y; Cai D; Liu B Rev Bras Cir Cardiovasc; 2015; 30(2):159-63. PubMed ID: 26107446 [TBL] [Abstract][Full Text] [Related]
15. Role of stent design and coatings on restenosis and thrombosis. Hara H; Nakamura M; Palmaz JC; Schwartz RS Adv Drug Deliv Rev; 2006 Jun; 58(3):377-86. PubMed ID: 16650911 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cell seeding promotes reendothelialization of the endovascular stent. Wu X; Wang G; Tang C; Zhang D; Li Z; Du D; Zhang Z J Biomed Mater Res A; 2011 Sep; 98(3):442-9. PubMed ID: 21661093 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia. Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819 [TBL] [Abstract][Full Text] [Related]
19. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis. Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653 [TBL] [Abstract][Full Text] [Related]
20. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis. Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]